STAA STAAR Surgical Company

NASDAQ
$26.72

STAAR Surgical Company (STAA) is expected to report earnings on February 3, 2027, after the market close. The consensus earnings estimate is a loss of $0.01 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -6.3% since its last earnings release on November 4, 2026.

STAAR Surgical Beat Expectations
Wednesday, November 4, 2026 · 4:01 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 3
Wednesday · 4:00 PM ET
Earnings Whisper
-
vs ($0.01) (GAAP)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $26.72

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About STAAR Surgical Company

STAAR Surgical designs, develops, manufactures and sells implantable lenses for the eye. The Company is a maker of lenses used in corrective surgery, and it also makes lenses for use in surgery that treats cataracts.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.